This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

ResMed Inc (RMD)

NYSE: Health Care

Company Income Statement
Jun 2015 Jun 2014 Jun 2013 Jun 2012
Sales 1.68B 1.55B 1.51B 1.37B
Cost of Sales 603.13M 501.47M 505.66M 475.90M
Gross Operating Profit 1.08B 1.05B 1.01B 892.62M
Selling, General, and Administrative Expenses 478.63M 450.41M 430.80M 401.62M
Research & Development 114.86M 118.23M 144.89M 109.73M
Operating Income before D & A (EBITDA) 482.29M 484.87M 433.10M 381.26M
Depreciation & Amortization 73.06M 73.45M 78.28M 85.86M
Interest Income 0.00 31.24M 38.87M 33.87M
Other Income - Net 32.46M 884.00K -2.19M 8.46M
Special Income / Charges 0.00 0.00 0.00 -1.00M
Total Income Before Interest Expenses (EBIT) 441.69M 437.21M 391.51M 336.73M
Interest Expense 5.78M 6.13M 6.39M 4.79M
Pre-Tax Income 435.92M 431.08M 385.12M 331.94M
Income Taxes 83.03M 85.81M 77.99M 77.09M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 352.89M 345.27M 307.13M 254.85M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 352.89M 345.27M 307.13M 254.85M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 352.89M 345.27M 307.13M 254.85M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
352.89M 351.60M 307.13M 255.85M
Preferred Dividends
Net Income Available To Common 352.89M 345.27M 307.13M 254.85M
Basic EPS from Continuing Ops. 2.51 2.44 2.15 1.75
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 2.51 2.44 2.15 1.75
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 2.51 2.44 2.15 1.75
Basic Normalized Net Income/Share 2.51 2.49 2.15 1.75
EPS fr Continuing Ops. 2.47 2.39 2.10 1.71
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 2.47 2.39 2.10 1.71
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 2.47 2.39 2.10 1.71
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.47 2.44 2.10 1.71
Dividends Paid per Share 1.12 1.00 0.68 0.00
RMD News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for RMD

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 2 3 3
Moderate Buy 1 1 1 1
Hold 5 4 4 4
Moderate Sell 0 0 0 0
Strong Sell 2 1 1 2
GET RMD ANALYST REPORT

RMD Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs